We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Funded by By-Health.
https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-022-03558-5
Back in stock https://www.amazon.co.uk/Fruitflow-Pressure-Supplement-Function-Circulation/dp/B07D6CTRZ9
Aww bless. You were saying the same thing when shares could be bought at a third of today's price. Anyone following your beliefs would have done themselves out of a very nice gain. But then, anyone who believes you are genuine needs their bumps feeling IMO
Promising Gixer , come on some major food manufacturer buy PXS .
Had a quick scan over it earlier and seems to be to do with not being able to obtain EFSA health claim for tomatoes or tomato products.
I did like this section though.
"EFSA has evaluated 30 requests for approval of health claims referred to tomatoes and/or lycopene, both as a specific and individual compound, component of a food or constituent of a mixture in a commercial product. ............................
Of the 30 applications submitted, 29 obtained an unfavorable scientific opinion and only one health claim was approved, under article 13.5. The approved health claim is for a concentrated extract of tomato soluble in water (WSTC). This extract is marketed under the patented name of Fruitflow® (FF) with two forms of presentation: WSTC I and II."
Telling us what we already know
https://www.frontiersin.org/articles/10.3389/fnut.2022.849841/full#h8
Department of Nutrition and Food Science, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain
Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United States
Cardiovascular disease (CVD) includes a group of disorders of the heart and blood vessels that includes numerous problems, many of which are related to the process called atherosclerosis. The present work is aimed to analyze the most relevant studies examining the potentially beneficial effects of tomato products on both CVD prevention and antiplatelet aggregation as well as an European Food Safety Authority health claims evaluation on tomato and tomato products. To date, only one health claim has been approved for a concentrated extract of tomato soluble in water (WSTC) marketed under the patented name of Fruitflow® with two forms of presentation: WSTC I and II, with the following claim “helping to maintain normal platelet aggregation, which contributes to healthy blood flow.” Other studies also demonstrate similar beneficial effects for fresh tomatoes, tomato products and tomato pomace extracts.
Conclusions
With regard to the association between tomato products, cardiovascular disease prevention and antiplatelet aggregation, in order to obtain EFSA approval for a related health claim, main research gaps are related to the lack of intervention studies on healthy humans (those with no history of serious disease or hemostatic disorders). At present, with the exception of WSTC studies, most of the clinical trials are performed on individuals with some CV risk factor. With independence of study duration which can be easily fit the 4 weeks required, other difficulty is the use of valid markers to prove the percentage of inhibition in platelet aggregation according to EFSA which should be measured using light transmission aggregometry (LTA) using well-accepted and standardized protocols. Finally, as all components found in the tomato extracts are originally in fresh tomato and tomato products, very convenient and appreciated food products by consumers, future directions on this research topic could be focused on the study of mechanism by which tomatoes and tomato products contribute to cardiovascular health to be considered valued as functional foods.
Looks like that link is not working , here’s the jist of it . “Hologram Sciences' Inaugural Innovation Summit
On February 22, 2022, the Hologram Sciences Leadership team hosted the company’s first nutrition innovation summit, broadcast live from Kaiseraugst Switzerland. Over 500 attendees registered to learn about Hologram’s personalized nutrition offering, the speed of progress in the personalized nutrition market and to be inspired about future partnership opportunities in the personalized nutrition space. During the event, Hologram unveiled its new brand, PhenologyTM, focused on women's health and announced its strategic partnership with Inne, a Berlin-based start-up focusing on a novel, non-invasive diagnostic platform.
Making it personal
Launched by DSM just under a year ago, Hologram Sciences™ is a dedicated entity for consumer-facing personalized nutrition solutions. Hologram’s first brand, d.velopTM, launched last May in record time—just 81 days from inception to launch. Offering a personalized approach to immunity, d.velopTM combines in-home vitamin D tests, proprietary fast-acting vitamin D supplements and an interactive app offering personalized insights on your immunity status, as well as nutrition and lifestyle coaching. The entire experience, encompassing digital platform, coaching, diagnostic and nutritional product was fine tuned in under three months. The brand has been embraced by consumers, with double-digit sales growth, high rates of subscription and conversion and a wealth of insights on how Hologram is advancing its mission to raise vitamin D levels.
Introducing timely, tailored, natural menopausal management
After the success of d.velopTM, the team is turning its attention to women’s health. Hologram Sciences’ new consumer brand, PhenologyTM, offers advanced at-home diagnostics, hormone tracking and custom insights for women before, during and after menopause. Fully personalized to their unique needs, users can follow a targeted wellness program with appropriate supplements and science-backed, naturally powerful health and beauty essentials. They can also access one-on-one coaching and expert advice to unlock timely relief throughout their menopause journey.”
No mention of ff but I can see some likely fits with pxs and By health https://www.dsm.com/human-nutrition/en/talking-nutrition/hologram-sciences-reveals-latest-brand-at-innovation-summit.html?utm_source=marketo&utm_medium=email&utm_campaign=hnh-issue-33&utm_term=subscribers-global&utm_content=hologram-science&utm_vehicle=dsm-newsletter&mkt_tok=MzM5LVNYVy03NjEAAAGDK_5uuY9l5izxqlcjlJRlvl6SEBn4P8k_6V3cpFrX72VDsM_K6cm3QL4hUh2oeAWmHzJHt3dBnZyxHv8cHQY7OsnSvZc_m-PzYZz4MawRtSJsf3A
Crystal Palace F.C. Wins the Generation Cup
https://pbs.twimg.com/media/FNveFplXEAEufMT?format=jpg&name=4096x4096
https://twitter.com/i/status/1503049749313646597
I see by health have become the supplier of sports nutrition to 70 Chinese national teams , hope Gym max are in on that ! http://www.by-health.com/en/aboutus/news/4499/
A notably succinct article on FF just pooped up in Vietnam.....
https://www-nhathuocankhang-com.translate.goog/ban-tin-suc-khoe/fruitflow-la-gi-cong-dung-cua-fruitflow-doi-voi-suc-khoe-tim-mach-1419231?_x_tr_sl=vi&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc
W$
You'd have thought those in the know will be taking positions here soon then if it is all going to go through. Stand by for action . But don't hold your breath.
By-Health currently expects to be in a position to complete the last of its eight studies and file its regulatory submission to the SAMR for Fruitflow in the first half of 2022. If By-Health is successful in obtaining a new permitted health function claim it is currently expected that this would result in some significant orders for Fruitflow, potentially at a multiple of current total sales values.
-———————-
Hopefully submitted within the next 3 months.
"By-Health's regulatory clearance preparations for Fruitflow were originally focussed on obtaining blue cap health claim status for some Fruitflow based products in China, under the existing 27 permitted health function claim structure.
By-Health is now working on an extensive regulatory submission to the SAMR for Fruitflow, seeking to establish a new permitted health function claim for foods such as Fruitflow that can demonstrate an anti-platelet effect, inhibiting platelet function and conferring beneficial effects for people who are at risk of platelet hyperactivity-associated thrombosis - the aberrant blood clots which lead to heart attacks and strokes."...............................
"By-Health currently expects to be in a position to complete the last of its eight studies in 2022, and it will file its regulatory submission to the SAMR for Fruitflow at the appropriate time seeking to obtain a new permitted health function claim which would be in addition to the currently defined list of 27 (reducing to 24) permitted claims. Subject to the timing the new anti-platelet claim, if approved, would therefore represent the 28th - or the 25th - permitted health function claim in China."
https://otp.investis.com/clients/uk/provexis_plc/rns/regulatory-story.aspx?cid=1569&newsid=1523432
Hopefully get an update when they have submitted the health function claim.
Hopefully end of March or beginning of April 2022
So are we thinking a few years until blue hat then?
Not in a rush, hope to be holding more when it comes through.
Thanks sphinx
From the finals “By-Health currently expects to be in a position to complete the last of its eight studies and file its regulatory submission to the SAMR for Fruitflow in the first half of 2022”
I know some will ask when the print comes through. It’s me buying. My name seems to have got lost I was xpub.
Any ideas when we might hear something regarding blue hat?
Funny how this muppet appears out of the blue every now and then, it's like he has a check list of tasks.
The the Bid/Ask rises. Hmmmm.
Must be so galling that his noise was just the same when shares could be got in the .3's, an epic fail on his part.
It's the same with 90% of companies on AIM. I've said this before, but if it was easy to turn a fledgling company with a tiny mcap into a multi £bn organisation, then everybody would be doing it. I know I couldn't, and you're clearly not because you wouldn't be wasting so much of your time ****ging off a company you're not invested in. For anyone with the patience to see this through to a hoped-for conclusion, good for you & good luck. For anyone else, goodbye & good luck.
ever
if bigpharma think they could make money with FF, they would be very interested.
Just need someone to convince them...........
Wdreamin$
Wellsite , you need to watch this , big pharma and Gov's are not interested in helping us .
https://www.*****ute.com/video/q1fuh8DinHrL/